HOME › DRUGS › SOFOSBUVIR;VELPATASVIR;VOXILAPREVI
ACTIVE SUBSTANCE / INN

SOFOSBUVIR;VELPATASVIR;VOXILAPREVI

Brand name(s): Vosevi
EMA LISTED
AUTHORISED
Hepatitis C, Chronic
ACTIVE SUBSTANCE
Sofosbuvir;Velpatasvir;Voxilaprevi
REGULATORS
EMA
SPONSORS / MAH
Gilead Sciences Ireland UC
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VoseviGilead Sciences Ireland UCAuthorised26/07/2017Hepatitis C, Chronic

FULL INTELLIGENCE ON SOFOSBUVIR;VELPATASVIR;VOXILAPREVI

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →